AmerisourceBergen gets Express Scripts job; Catalent likes single-use reactors;

> AmerisourceBergen ($ABC) has been tapped to be the drug distributor for pharmaceutical benefit manager Express Scripts ($ESRX) beating out Cardinal Health ($CAH). Story

> Catalent has replaced its stainless steel bioreactors at its biologics facility in Middleton, WI, with disposable technology. Story

> Alnylam Pharmaceuticals received a $3.2 million milestone payment from GlaxoSmithKline ($GSK) for new manufacturing technology for a GSK vaccine. Item

> Granules India reports higher sales as demand from China drove its API business. Story

> A congressional report says some U.S. pharmacies are selling all of their inventories into the gray market at huge markups. Story

And Finally... Canada is looking at establishing a bidding process to buy generics nationally in hopes of getting them cheaper. Story


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.